The DOI matches its Crossref record; 26 of the 27 references it cites were found in a registry or an index.
Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institut Gustave-Roussy Breast Cancer Group
Abstract
PURPOSES: A randomized trial was conducted to compare tumorectomy and breast irradiation with modified radical mastectomy. We have analyzed the patterns of failure in each arm of the trial and the prognostic factors that have an independent effect on treatment failures and overall survival. PATIENTS AND METHODS: The trial included 179 patients with breast cancer of up to 20 mm in diameter at macroscopic examination. Eighty-eight patients had conservative management and 91 a mastectomy. All patients had axillary dissection with frozen-section examination. For patients with positive axillary nodes (N+), a second randomization was performed: lymph node irradiation versus no further regional treatment. Patterns of failure were determined by a competing-risk approach and multivariate analysis. A prognostic-score was determined by multivariate analysis. RESULTS: Overall survival, distant metastasis, contralateral breast cancer, new primary malignancy, and locoregional recurrence rates were not significantly different between the two surgical groups, or between lymph node irradiation groups. Most recurrences appeared during the first 10 years. Three distinct prognostic groups were determined taking into account age, tumor size, histologic grading, and number of positive axillary nodes. CONCLUSION: Long-term results support conservative treatment with limited surgery and systematic breast irradiation as a safe procedure for the management of small breast cancers. Four easily obtainable clinical and histologic factors may be combined in a prognostic score that is highly predictive of overall and event-free survival.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This has resulted in improved outcomes in a number of different cancers (2, 342–350).”
From Adrenocortical carcinoma (2014) · cites this paper as [342]
Citations
Cites
TNM Classification of Malignant Tumours
Hermanek, P., & Sobin, L. H. (1987) · Springer eBooks · doi:10.1007/978-3-642-82982-6 · Cited by 16,077
Fisher, B., Redmond, C. K., POISSON, R., Margolese, R. G., Wolmark, N., Wickerham, D. L., Fisher, E. R., Deutsch, M., Caplan, R. J., Pilch, Y. H., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903303201302 · Cited by 1,582
Jacobson, J. A., Danforth, D. N., Cowan, K. H., d'Angelo, T., Steinberg, S. M., Pierce, L., Lippman, M. E., Lichter, A. S., Glatstein, E., & Okunieff, P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504063321402 · Cited by 892
Radiotherapy after Breast-Preserving Surgery in Women with Localized Cancer of the Breast
Veronesi, U., Luini, A., Vecchio, M. D., Greco, M., Galimberti, V. E., Merson, M., Rilke, F. O., Sacchini, V., Saccozzi, R., Savio, T., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306033282202 · Cited by 749
Statistical aspects of prognostic factor studies in oncology
Simon, R. M., & Altman, D. G. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.192 · Cited by 586
Sarrazin, D., Lê, M. G., Arriagada, R., Contesso, G., Fontaine, F., Spielmann, M., Rochard, F., Chevalier, T. L., & Lacour, J. (1989) · Radiotherapy and Oncology · doi:10.1016/0167-8140(89)90165-5 · Cited by 556
Significance of ipsilateral breast tumour recurrence after lumpectomy
Fisher, B., Anderson, S., Fisher, E. R., Redmond, C. K., Wickerham, D. L., Wolmark, N., Mamounas, E. P., Deutsch, M., & Margolese, R. G. (1991) · The Lancet · doi:10.1016/0140-6736(91)90475-5 · Cited by 551
Veronesi, U., Banfi, A., Salvadori, B., Luini, A., Saccozzi, R., Zucali, R., Marubini, E., Vecchio, M. D., Boracchi, P., Marchini, S., et al. (1990) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(90)90113-8 · Cited by 489
Scholl, S., Fourquet, A., Asselain, B. J. R., Pierga, J., Vilcoq, J. R., Durand, J. C., Dorval, T., Palangié, T., Jouve, M., Beuzeboc, P., et al. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(94)90537-1 · Cited by 424
Clark, R. M., McCulloch, P. B., Levine, M. N., Lipa, M., Wilkinson, R. H., Mahoney, L. J., Basrur, V. R., Nair, B. D., McDermot, R. S., Wong, C. S., et al. (1992) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/84.9.683 · Cited by 395
Cited by
Sorted by citations
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A. E., ELIAS, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,612
Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Moran, M. S., Abraham, J., Aft, R., Agnese, D. M., Allison, K. H., Anderson, B. M., Burstein, H. J., Chew, H. K., Dang, C. T., et al. (2022) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2022.0030 · Cited by 993
Else, T., Kim, A. C., Sabolch, A., Raymond, V. M., Kandathil, A., Caoili, E. M., Jolly, S., Miller, B. S., Giordano, T. J., & Hammer, G. D. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1029 · Cited by 892
Recht, A., Edge, S. B., Solin, L. J., Robinson, D. S., Estabrook, A., Fine, R. E., Fleming, G. F., Formenti, S. C., Hudis, C. A., Kirshner, J. J., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.5.1539 · Cited by 816
Poggi, M. M., Danforth, D. N., Sciuto, L. C., Smith, S. L., Steinberg, S. M., Liewehr, D. J., Menard, C., Lippman, M. E., Lichter, A. S., & Altemus, R. M. (2003) · Cancer · doi:10.1002/cncr.11580 · Cited by 569
Understanding of regional variation in the use of surgery
Birkmeyer, J. D., Reames, B. N., McCulloch, P. G., Carr, A. J., Campbell, W. B., & Wennberg, J. E. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61215-5 · Cited by 533
Livi, L., Meattini, I., Marrazzo, L., Simontacchi, G., Pallotta, S., Saieva, C., Paiar, F., Scotti, V., Cardillo, C. D. L., Bastiani, P., et al. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2014.12.013 · Cited by 466
“The majority of early breast recurrences occur at the site of the original primary tumour, regardless of whether radiotherapy (RT) has been administered or whether the margins are involved [3,4].”
BackgroundCarlson, R. W., Allred, D. C., Anderson, B. O., Burstein, H. J., Carter, W. B., Edge, S. B., Erban, J. K., Farrar, W. B., Goldstein, L. J., Gradishar, W. J., et al. (2009) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2009.0012 · Cited by 456
Meattini, I., Marrazzo, L., Saieva, C., Desideri, I., Scotti, V., Simontacchi, G., Bonomo, P., Greto, D., Mangoni, M., Scoccianti, S., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.00650 · Cited by 452
Boughey, J. C., McCall, L. M., Ballman, K. V., Mittendorf, E. A., Ahrendt, G. M., Wilke, L. G., Taback, B., Leitch, A. M., Flippo-Morton, T. S., & Hunt, K. K. (2014) · Annals of Surgery · doi:10.1097/sla.0000000000000924 · Cited by 444
Gao, X., Fisher, S. G., & Emami, B. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(03)00203-7 · Cited by 372
Vinh‐Hung, V., & Verschraegen, C. F. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh013 · Cited by 366
Standard for Breast Conservation Therapy in the Management of Invasive Breast Carcinoma
Morrow, M., Strom, E. A., Bassett, L. W., Dershaw, D. D., Fowble, B., Giuliano, A. E., Harris, J. R., O’Malley, F. P., Schnitt, S. J., Singletary, S. E., et al. (2002) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.52.5.277 · Cited by 321
“Overall, the incidence of a recurrence in the treated breast ranges from 3 to 20 percent (Table 3).(3,4,6,7,9,10) The majority of failures in the treated breast can be salvaged with mastectomy, and survival following such treatment is approximately 70 percent at five years.”
BackgroundInvasive Breast Cancer Version 1.2016, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A. E., ELIAS, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2016) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2016.0037 · Cited by 307
Newman, E. A., Guest, A. B., Helvie, M. A., Roubidoux, M. A., Chang, A. E., Kleer, C. G., Diehl, K. M., Cimmino, V. M., Pierce, L. J., Hayes, D. F., et al. (2006) · Cancer · doi:10.1002/cncr.22266 · Cited by 293
Freedman, G. M., Fowble, B., Hanlon, A., Nicolaou, N., Fein, D. A., Hoffman, J., Sigurdson, E. R., Boraas, M. C., & Goldstein, L. J. (1999) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(99)00112-1 · Cited by 272
Pierce, L., Strawderman, M., Narod, S., Oliviotto, I., Eisen, A., Dawson, L., Gaffney, D., Solin, L., Nixon, A., Garber, J., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.19.3360 · Cited by 270
Role for Intraoperative Margin Assessment in Patients Undergoing Breast-Conserving Surgery
Cabıoğlu, N., Hunt, K. K., Şahin, A. A., Kuerer, H. M., Babiera, G. V., Singletary, S. E., Whitman, G. J., Ross, M. I., Ames, F. C., Feig, B. W., et al. (2007) · Annals of Surgical Oncology · doi:10.1245/s10434-006-9236-0 · Cited by 253
Jones, H., Antonini, N. F., Hart, A. A. M., Peterse, J. L., Horiot, J.-C., Collin, F., Poortmans, P. M., Oei, S. B., Collette, L., Struikmans, H., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.5764 · Cited by 238
“noma treated with BCT will have a local relapse within 10 years.(1-10) We and Romestaing et al(11-13)”
BackgroundPolgár, C., Sulyok, Z., Fodor, J. C., Orosz, Z., Major, T., Takácsi‐Nagy, Z., Mangel, L., Somogyi, A., Kásler, M., & Németh, G. (2002) · Journal of Surgical Oncology · doi:10.1002/jso.10110 · Cited by 229
Randomized Trials of Breast-Conserving Therapy Versus Mastectomy for Primary Breast Cancer
Jatoi, I., & Proschan, M. A. (2005) · American Journal of Clinical Oncology · doi:10.1097/01.coc.0000156922.58631.d7 · Cited by 226
Cardiac Morbidity of Adjuvant Radiotherapy for Breast Cancer
Patt, D. A., Goodwin, J. S., Kuo, Y., Freeman, J. L., Zhang, D. D., Buchholz, T. A., Hortobágyi, G. N., & Giordano, S. H. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.13.755 · Cited by 224
Collette, S., Collette, L., Budiharto, T., Horiot, J.-C., Poortmans, P. M., Struikmans, H., den Bogaert, W. F. V., Fourquet, A., Jager, J. J., Hoogenraad, W. J., et al. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.07.032 · Cited by 227
Are Mastectomy Rates Really Increasing in the United States?
Habermann, E. B., Abbott, A. M., Parsons, H. M., Virnig, B. A., Al‐Refaie, W. B., & Tuttle, T. M. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.6774 · Cited by 224
Current Perceptions Regarding Surgical Margin Status After Breast-Conserving Therapy
Taghian, A. G., Mohiuddin, M. M., Jagsi, R., Goldberg, S. I., Ceilley, E., & Powell, S. N. (2005) · Annals of Surgery · doi:10.1097/01.sla.0000157272.04803.1b · Cited by 207
Nipple-sparing mastectomy in breast cancer: a viable option?
Cense, H. A., Rutgers, E. J. T., Cardozo, M. L., & van Lanschot, J. J. B. (2001) · European Journal of Surgical Oncology · doi:10.1053/ejso.2001.1130 · Cited by 203
Meric, F., Mirza, N. Q., Vlastos, G., Buchholz, T. A., Kuerer, H. M., Babiera, G. V., Singletary, S. E., Ross, M. I., Ames, F. C., Feig, B. W., et al. (2003) · Cancer · doi:10.1002/cncr.11222 · Cited by 201
Chen, C. M., Cano, S., Klassen, A. F., King, T. A., McCarthy, C. M., Cordeiro, P. G., Morrow, M., & Pusic, A. L. (2010) · The Breast Journal · doi:10.1111/j.1524-4741.2010.00983.x · Cited by 196
Ottini, L., Palli, D., Rizzo, S., Federico, M., Bazan, V., & Russo, A. D. (2009) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2009.04.003 · Cited by 201
“[106] Arriagada R, Le MG, Rochard F, Contesso G.”
BackgroundGu, J., Groot, G., Boden, C., Busch, A. J., Holtslander, L. F., & Lim, H. J. (2018) · Clinical Breast Cancer · doi:10.1016/j.clbc.2017.12.013 · Cited by 198
Surgical Margins in Lumpectomy for Breast Cancer — Bigger Is Not Better
Morrow, M., Harris, J. R., & Schnitt, S. J. (2012) · New England Journal of Medicine · doi:10.1056/nejmsb1202521 · Cited by 188
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A. E., ELIAS, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2015) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2015.0060 · Cited by 185
Arriagada, R., Lê, M. G., Guinebretière, J.-M., Dunant, A., Rochard, F., & Tursz, T. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg452 · Cited by 179
Self-citationEvans, R. A. (2003) · Cancer · doi:10.1002/cncr.11792 · Cited by 171
Tumor-infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma
Smyrk, T. C., Watson, P. A., Kaul, K. L., & Lynch, H. T. (2001) · Cancer · doi:10.1002/1097-0142(20010615)91:12 · Cited by 522
Should internal mammary lymph nodes in breast cancer be a target for the radiation oncologist?
Freedman, G. M., Fowble, B. L., Nicolaou, N., Sigurdson, E. R., Torosian, M. H., Boraas, M. C., & Hoffman, J. P. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(99)00481-2 · Cited by 172
MRI detection of distinct incidental cancer in women with primary breast cancer studied in IBMC 6883
Schnall, M. D., Blume, J. D., Bluemke, D. A., DeAngelis, G. A., DeBruhl, N. D., Harms, S. E., Heywang-Köbrunner, S. H., Hylton, N. M., Kuhl, C. K., Pisano, E. D., et al. (2005) · Journal of Surgical Oncology · doi:10.1002/jso.20381 · Cited by 164
“The local recurrence rates for breast conservation therapy (BCT) vary from 3% to 19% at 10 years [16–23].”
BackgroundMajor, T., Gutiérrez, C., Guix, B., Limbergen, E. V., Strnad, V., & Polgár, C. (2016) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2015.12.006 · Cited by 164
Trends in Racial and Age Disparities in Definitive Local Therapy of Early-Stage Breast Cancer
Freedman, R. A., He, Y., Winer, E. P., & Keating, N. L. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.9234 · Cited by 161
The curability of breast cancer and the treatment of advanced disease
Guarneri, V., & Conte, P. (2004) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-004-1538-5 · Cited by 159
Carlson, R. W., Allred, D. C., Anderson, B. O., Burstein, H. J., Carter, W. B., Edge, S. B., Erban, J. K., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2011) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2011.0016 · Cited by 152
Standard for the Management of Ductal Carcinoma In Situ of the Breast (DCIS)
Morrow, M., Strom, E. A., Bassett, L. W., Dershaw, D. D., Fowble, B., Harris, J. R., O’Malley, F. P., Schnitt, S. J., Singletary, S. E., & Winchester, D. P. (2002) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.52.5.256 · Cited by 151
Rew, D. A. (2008) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2008.11.001 · Cited by 149
Obedian, E., FISCHER, D. B., & Haffty, B. G. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.12.2406 · Cited by 148
Alpert, T. E., Kuerer, H. M., Arthur, D. W., Lannin, D. R., & Haffty, B. G. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.02.035 · Cited by 142
Strnad, V., Hannoun‐Lévi, J., Guinot, J. L., Lössl, K., Kauer-Dorner, D., Resch, A., Kovács, G., Major, T., & Limbergen, E. V. (2015) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2015.06.010 · Cited by 138
“therapy (WBRT) is the current standard treatment for nearly all women with early breast cancer [1,3,5,14,27,50,53].”
BackgroundOnitilo, A. A., Engel, J. M., Stankowski, R. V., & Doi, S. A. R. (2014) · Clinical Medicine & Research · doi:10.3121/cmr.2014.1245 · Cited by 134
Caudle, A. S., Yu, T., Tucker, S. L., Bedrosian, I., Litton, J. K., Gonzalez-Angulo, A. M., Hoffman, K. E., Meric‐Bernstam, F., Hunt, K. K., Buchholz, T. A., et al. (2012) · Breast Cancer Research · doi:10.1186/bcr3198 · Cited by 136
“Based on data from prospective studies, breast conservation therapy (BCT), defined as lumpectomy with whole breast irradiation, is now accepted as oncologically equivalent to mastectomy in terms of overall survival (OS) [1-6].”
MethodFinancial Costs and Burden Related to Decisions for Breast Cancer Surgery
Greenup, R. A., Rushing, C. N., Fish, L. J., Campbell, B. M., Tolnitch, L., Hyslop, T., Peppercorn, J. M., Wheeler, S. B., Zafar, S. Y., Myers, E. R., et al. (2019) · Journal of Oncology Practice · doi:10.1200/jop.18.00796 · Cited by 136
Winchester, D. P., & Cox, J. D. (1998) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.48.2.83 · Cited by 135
Fowble, B., Hanlon, A., Freedman, G., Nicolaou, N., & Anderson, P. (2001) · International Journal of Radiation Oncology, Biology, Physics · doi:10.1016/s0360-3016(01)01665-0 · Cited by 136
Long-term results of local recurrence after breast conservation treatment for invasive breast cancer
Doyle, T., Schultz, D. J., Peters, C. A., Harris, E. E. R., & Solin, L. J. (2001) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(01)01625-x · Cited by 132
Al‐Hilli, Z., & Wilkerson, A. D. (2021) · Surgical Clinics of North America · doi:10.1016/j.suc.2021.06.014 · Cited by 145
Jorns, J. M., Visscher, D. W., Sabel, M. S., Breslin, T. M., Healy, P. N., Daignaut, S., Myers, J. L., & Wu, A. J. (2012) · American Journal of Clinical Pathology · doi:10.1309/ajcp4iemxcj1gdts · Cited by 122
Locoregionally recurrent breast cancer: incidence, risk factors and survival
Clemons, M. J., Danson, S. J., Hamilton, T., & Goss, P. E. (2001) · Cancer Treatment Reviews · doi:10.1053/ctrv.2000.0204 · Cited by 117
Fowble, B. L., Hanlon, A. L., Freedman, G. M., Nicolaou, N., Hoffman, J., Sigurdson, E. R., Boraas, M. C., Torosian, M. H., & Goldstein, L. J. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)00526-5 · Cited by 116
A Systematic Overview of Radiation Therapy Effects in Breast Cancer
Rutqvist, L. E., Rose, C., & Cavallin-Ståhl, E. K. (2003) · Acta Oncologica · doi:10.1080/02841860310014444 · Cited by 116
“(pro (16) C1, (17) C2, (18) C3, (15) C3; con (19) C1).”
InfluentialPopulation‐based analysis of occult primary breast cancer with axillary lymph node metastasis
Walker, G. V., Smith, G. L., Perkins, G. H., Oh, J., Woodward, W. A., Yu, T., Hunt, K. K., Hoffman, K. E., Strom, E. A., & Buchholz, T. A. (2010) · Cancer · doi:10.1002/cncr.25197 · Cited by 119
“This result most likely represents the extrapolation of prospective, randomized controlled trials indicating that BCT produces outcomes comparable to those produced by mastectomy in patients who have stage I and II breast cancer and the single-institution reports indicating success with this approach.(11-17) Although…”
ResultCampbell, E. J., & Romics, L. (2017) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s113742 · Cited by 108
Lawenda, B. D., Taghian, A. G., Kachnic, L. A., Hamdi, H., Smith, B. L., Gadd, M. A., Mauceri, T., & Powell, S. N. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(03)00071-3 · Cited by 108
Assessing breast tumor margin by multispectral photoacoustic tomography
Li, R., Wang, P., Lan, L., Lloyd, F. P., Goergen, C. J., Chen, S., & Cheng, J. (2015) · Biomedical Optics Express · doi:10.1364/boe.6.001273 · Cited by 111
Partial breast irradiation as second conservative treatment for local breast cancer recurrence
Hannoun‐Lévi, J., Houvenaeghel, G. F., Ellis, S., Teissier, E., Alzieu, C., Lallement, M., & Cowen, D. M. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2004.05.035 · Cited by 106
Campana, L. G., Valpione, S., Falci, C., D, S. M. M., Basso, M., Corti, L., Balestrieri, N., Marchet, A., & Rossi, C. R. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2095-4 · Cited by 104
Predictors of Local Recurrence After Breast-Conservation Therapy
Horst, K. C., Smitt, M. C., Goffinet, D. R., & Carlson, R. W. (2005) · Clinical Breast Cancer · doi:10.3816/cbc.2005.n.001 · Cited by 105
Triple-Negative Breast Cancer Is Not a Contraindication for Breast Conservation
Adkins, F. C., Gonzalez-Angulo, A. M., Lei, X. J., Hernandez-Aya, L. F., Mittendorf, E. A., Litton, J. K., Wagner, J. L., Hunt, K. K., Woodward, W. A., & Meric‐Bernstam, F. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-1920-z · Cited by 105
Santiago, R. J., Wu, L., Harris, E. E. R., Fox, K. R., Schultz, D., Glick, J. H., & Solin, L. J. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(03)01460-3 · Cited by 101
A shorter fractionation schedule for postlumpectomy breast cancer patients
Shelley, W. E., Brundage, M., Hayter, C. R. R., Paszat, L. F., Zhou, S., & Mackillop, W. J. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)00567-8 · Cited by 98
Pattern of local recurrence after conservative surgery and whole-breast irradiation
Freedman, G. M., Anderson, P. R., Hanlon, A. L., Eisenberg, D. F., & Nicolaou, N. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2004.08.026 · Cited by 93
The Impact of Age on Outcome in Early-Stage Breast Cancer
Beadle, B. M., Woodward, W. A., & Buchholz, T. A. (2010) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2010.09.001 · Cited by 96
Nash, R., Goodman, M. G., Lin, C. C., Freedman, R. A., Dominici, L. S., Ward, K. C., & Jemal, A. (2017) · JAMA Surgery · doi:10.1001/jamasurg.2017.0115 · Cited by 91
Spronk, I., Schellevis, F., Burgers, J. S., de Bock, G. H., & Korevaar, J. C. (2018) · The Breast · doi:10.1016/j.breast.2018.03.011 · Cited by 89
Mittendorf, E. A., Buchholz, T. A., Tucker, S. L., Meric‐Bernstam, F., Kuerer, H. M., Gonzalez-Angulo, A. M., Bedrosian, I., Babiera, G. V., Hoffman, K. E., Yi, M., et al. (2013) · Annals of Surgery · doi:10.1097/sla.0b013e3182805c4a · Cited by 91
A device for real-time, intraoperative margin assessment in breast-conservation surgery
Karni, T., Pappo, I., Sandbank, J., Lavon, O., Stahl-Kent, V., Spector, R., Morgenstern, S., & LELCUK, S. (2007) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2007.06.013 · Cited by 90
“[5] Arriagada R, Le MG, Rochard F, Contesso G.”
BackgroundCompliance with breast‐conservation standards for patients with early‐stage breast carcinoma
White, J. R., Morrow, M., Moughan, J., Owen, J. B., Pajak, T. F., DesHarnais, S., Winchester, D. P., & Wilson, J. F. (2003) · Cancer · doi:10.1002/cncr.11141 · Cited by 89
Lê, M. G., Arriagada, R., Spielmann, M., Guinebretière, J., & Rochard, F. (2002) · Cancer · doi:10.1002/cncr.10572 · Cited by 87
“6 Moreover, the locoregional recurrence rate decreased in some of the breast-conserving treatment groups due to the use of systematic local irradiation.(1) However, it has not been established clearly whether the type of initial local treatment may influence survival after a local recurrence.”
BackgroundOptimal timing for adjuvant radiation therapy in breast cancer
Tsoutsou, P. P., Koukourakis, M. I., Azria, D., & Belkacémi, Y. (2008) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2008.09.002 · Cited by 87
“[6] Arriagada R, Le MG, Rochard F, et al.”
BackgroundSantiago, R. J., Harris, E. E. R., Qin, L., Hwang, W., & Solin, L. J. (2005) · Cancer · doi:10.1002/cncr.21071 · Cited by 87
Osborn, J. B., Keeney, G. L., Jakub, J. W., Degnim, A. C., & Boughey, J. C. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-1956-0 · Cited by 88
Intra-operative Sonography: A Valuable Aid During Breast-Conserving Surgery for Occult Breast Cancer
Haid, A., Knauer, M., Dunzinger, S., Jasarevic, Z., Köberle-Wührer, R., Schuster, A. H., Töpker, M., Haid, B., Wenzl, E., & Offner, F. A. (2007) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9490-9 · Cited by 85
Comprehensive Review of The Management of Internal Mammary Lymph Node Metastases in Breast Cancer
Klauber‐DeMore, N., Bevilacqua, J. B., Zee, K. J. V., Borgen, P. I., & Cody, H. S. (2001) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(01)01040-7 · Cited by 84
Controversies in the Treatment of Ductal Carcinoma in Situ
Barrio, A. V., & Zee, K. J. V. (2017) · Annual Review of Medicine · doi:10.1146/annurev-med-050715-104920 · Cited by 84
Brooks, J. M., Chrischilles, E. A., Scott, S. D., & Chen-Hardee, S. (2003) · Health Services Research · doi:10.1111/j.1475-6773.2003.00184.x · Cited by 81
“The RCT evidence supports the survival equivalence of BCSI and MAS for the ‘‘average’’ ESBC patient in each RCT (Veronesi et al. 1990; Arriagada et al. 1996; Jacobson et al. 1995; Fisher et al. 1995; van Dongen et al. 2000).”
BackgroundLim, M. C. K., Bellon, J. R., Gelman, R. S., Silver, B. J., Recht, A., Schnitt, S. J., & Harris, J. R. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.02.006 · Cited by 80
Farrus, B., Vidal‐Sicart, S., Velasco, M., Zanón, G., Fernández, P. L., Muñoz-Mateu, M., Santamaría, G., Albanell, J., & Biete, A. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2004.04.021 · Cited by 79
Camp, R., McAuliffe, P. F., Gilroy, J. S., Morris, C. G., Lind, S. D., Mendenhall, N. P., & Copeland, E. M. (2005) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2005.06.274 · Cited by 79
Bellavance, E. C., & Kesmodel, S. B. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00074 · Cited by 82
Galper, S., Blood, E., Gelman, R. S., Abner, A. L., Recht, A., Kohli, A., Wong, J. S., Smith, D. N., Bellon, J. R., Connolly, J. L., et al. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2004.06.011 · Cited by 79
Impact of non-axillary sentinel node biopsy on staging and treatment of breast cancer patients
Tanis, P. J., Nieweg, O. E., Olmos, R. A. V., Peterse, J. L., Rutgers, E. J. T., Hoefnagel, C. A., & Kroon, B. B. R. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600359 · Cited by 77
Mansell, J., Weiler-Mithoff, E. M., Stallard, S., Doughty, J., Mallon, E., & Romics, L. (2017) · The Breast · doi:10.1016/j.breast.2017.02.006 · Cited by 79
Cohen, L. G., de Moor, C., & Amato, R. J. (2001) · Cancer · doi:10.1002/1097-0142(20010515)91:10 · Cited by 110
Factors increasing local recurrence in breast-conserving surgery
Fatouros, M., Roukos, D. H., Arampatzis, I., Sotiriadis, A., Paraskevaidis, E. A., & Kappas, A. M. (2005) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.5.4.737 · Cited by 75
Breast conservation for male breast carcinoma
Golshan, M. A., Rusby, J. E., Dominguez, F., & Smith, B. L. (2007) · The Breast · doi:10.1016/j.breast.2007.05.012 · Cited by 74
Freedman, G. M., Hanlon, A. L., Fowble, B. L., Anderson, P. R., & Nicoloau, N. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.03.155 · Cited by 73
Guidelines for the management of symptomatic breast disease
(2005) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2005.02.006 · Cited by 73
EZH2 and ALDH-1 mark breast epithelium at risk for breast cancer development
Kunju, L. P., Cookingham, C., Toy, K. A., Chen, W., Sabel, M. S., & Kleer, C. G. (2011) · Modern Pathology · doi:10.1038/modpathol.2011.8 · Cited by 73
Twenty-five year results of the national cancer institute randomized breast conservation trial
Simone, N. L., Dan, T., Shih, J., Smith, S. L., Sciuto, L. C., Lita, E., Lippman, M. E., GLATSTEIN, E. J., Swain, S. M., Danforth, D. N., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1867-6 · Cited by 72
Weber, W. P., Engelberger, S., Viehl, C. T., Zanetti‐Dällenbach, R., Dell‐Kuster, S., Dirnhofer, S., Wruk, D., Oertli, D., & Marti, W. R. (2008) · World Journal of Surgery · doi:10.1007/s00268-008-9757-8 · Cited by 70
New Trends in Breast Cancer Management
Pomahač, B., Recht, A., May, J. W., Hergrueter, C. A., & Slavin, S. A. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000217626.88430.c3 · Cited by 72
Vicini, F. A., Horwitz, E. M., Lacerna, M. D., Brown, D. M., White, J. R., Dmuchowski, C., Kini, V. R., & Martinez, A. A. (1997) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(97)00555-5 · Cited by 72
Richards, G. M., Berson, A. M., Rescigno, J., Sanghavi, S. N., Siegel, B., Axelrod, D., Bernik, S. F., Scarpinato, V., & Mills, C. D. (2004) · Annals of Surgical Oncology · doi:10.1245/aso.2004.02.009 · Cited by 72
“Patients qualified for intracavitary brachytherapy if they met the following criteria: (1) age 45 years, (2) tumor 2 cm, (3) nodal status N1 or less (maximum of three nodes), (4) no distant metastasis, and (5) 2-mm microscopically negative margins after final surgery.”
Method
Metadata
- Authors
- Arriagada, R., Lê, M. G., Rochard, F., & Contesso, G.
- Affiliations
- Institut Gustave Roussy (FR)
- ORCID
- Venue
- Journal of Clinical Oncology
- Published
- 1996-05
- Volume
- 14
- Issue
- 5
- Pages
- 1558-1564
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1782647475
- Cited by
- 612
- References
- 27
- Citations by year
- 2026: 6 · 2025: 10 · 2024: 8 · 2023: 9 · 2022: 17 · 2021: 19 · 2020: 24 · 2019: 23 · 2018: 24 · 2017: 26 · 2016: 29 · 2015: 29 · 2014: 25 · 2013: 17 · 2012: 31
- FWCI
- 4.04
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Clinical Oncology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Health Sciences › Medicine › Pathology and Forensic Medicine › Breast Lesions and Carcinomas
- Health Sciences › Medicine › Obstetrics and Gynecology › Endometrial and Cervical Cancer Treatments
- Keywords
- early breast cancer, breast-conserving surgery, modified radical mastectomy, breast cancer radiotherapy, axillary lymph node irradiation, failure patterns, prognostic score, overall survival, locoregional recurrence, contralateral breast cancer, distant metastasis, small breast tumors
- MeSH terms
- Adult, Aged, Breast Neoplasms, Combined Modality Therapy, Female, Follow-Up Studies, Humans, Middle Aged, Neoplasm Recurrence, Local, Prognosis, Risk Factors, Mastectomy, Modified Radical, Mastectomy, Segmental, Survival Analysis, Treatment Failure
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review